Usana Health Sciences Analyst Ratings
Usana Health Sciences Analyst Ratings
While ratings are subjective and will change, the latest Usana Health Sciences (USNA) rating was a maintained with a price target of $57.00 to $49.00. The current price Usana Health Sciences (USNA) is trading at is $61.09, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/13/2023 | -14.05% | DA Davidson | $49 → $52.5 | Maintains | Neutral |
| 10/27/2022 | -19.78% | DA Davidson | $57 → $49 | Maintains | Neutral |
| 07/28/2022 | -6.69% | DA Davidson | $58 → $57 | Maintains | Neutral |
| 07/12/2022 | -5.05% | DA Davidson | $76 → $58 | Maintains | Neutral |
| 07/07/2022 | -13.24% | Jefferies | $78 → $53 | Downgrades | Hold → Underperform |
| 04/27/2022 | 24.42% | DA Davidson | $86 → $76 | Maintains | Neutral |
| 04/14/2022 | 40.79% | DA Davidson | → $86 | Initiates Coverage On | → Neutral |
| 02/10/2021 | 106.27% | Roth Capital | $107 → $126 | Maintains | Buy |
| 12/17/2020 | 75.17% | Roth Capital | → $107 | Initiates Coverage On | → Buy |
| 08/22/2019 | 6.41% | Jefferies | → $65 | Initiates Coverage On | → Hold |
| 07/03/2019 | 14.59% | Sidoti & Co. | $108 → $70 | Downgrades | Buy → Neutral |
| 04/16/2019 | — | Tigress Financial | Initiates Coverage On | → Buy | |
| 04/23/2018 | — | Pivotal Research | Downgrades | Buy → Hold |
| 日期 | 上/下行 | 分析師公司 | 价格目標變更 | 評級變更 | 上一頁/目前評分 |
|---|---|---|---|---|---|
| 02/13/2023 | -14.05% | 达戴维森 | 四十九元 → 五五元 | 維護 | 中性 |
| 2022 年 10 月 27 日 | -19.78% | 达戴维森 | 五十七美元 → 49 美元 | 維護 | 中性 |
| 2022 年 07 月 28 日 | -6.69% | 达戴维森 | 五十八美元 → 57 美元 | 維護 | 中性 |
| 2022 年 12 月 7 日 | -5.05% | 达戴维森 | 七十六元 → 五十八美元 | 維護 | 中性 |
| 2022 年 7 月 7 日 | -13.24% | 富瑞集團 | 七八美元 → 53 美元 | 降級 | 保持 → 表現不足 |
| 04/27/2022 | 24.42% | 达戴维森 | 八十六美元 → 76 美元 | 維護 | 中性 |
| 04/14/2022 | 40.79% | 达戴维森 | → 八十六美元 | 啟動覆蓋範圍 | → 中性 |
| 2021 年 2 月 10 日 | 106.27% | 羅斯資本 | 一百零七元 → 一百二十六 | 維護 | 購買 |
| 12/17/2020 | 75.17% | 羅斯資本 | → 107 美元 | 啟動覆蓋範圍 | → 購買 |
| 08/22/2019 | 6.41% | 富瑞集團 | → 六十五美元 | 啟動覆蓋範圍 | → 保持 |
| 07/03/2019 | 14.59% | 西多迪 & 有限公司. | 一百零八元 → 七十美元 | 降級 | 購買 → 中性 |
| 2019 年 4 月 16 日 | — | 母老虎金融 | 啟動覆蓋範圍 | → 購買 | |
| 04/23/2018 | — | 關鍵研究 | 降級 | 購買 → 持有 |
What is the target price for Usana Health Sciences (USNA)?
烏薩納健康科學（USNA）的目標價格是多少？
The latest price target for Usana Health Sciences (NYSE: USNA) was reported by DA Davidson on October 27, 2022. The analyst firm set a price target for $49.00 expecting USNA to fall to within 12 months (a possible -19.78% downside). 6 analyst firms have reported ratings in the last year.
DA 戴維森於 2022 年 10 月 27 日報導了烏薩納健康科學（紐約證交所代碼：USNA）的最新價格目標。該分析師公司設定了 $49.00 的價格目標，預計 USNA 將在 12 個月內下降（可能為 -19.78％ 的下行）。6 家分析師公司在去年報告了評級。
What is the most recent analyst rating for Usana Health Sciences (USNA)?
Usana 健康科學 (USNA) 的最新分析師評級為何？
The latest analyst rating for Usana Health Sciences (NYSE: USNA) was provided by DA Davidson, and Usana Health Sciences maintained their neutral rating.
Usana 健康科學（紐約證券交易所代碼：USNA）的最新分析師評級由 DA Davidson 提供，而 Usana 健康科學保持中立評級。
When is the next analyst rating going to be posted or updated for Usana Health Sciences (USNA)?
Usana 健康科學（USNA）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Usana Health Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Usana Health Sciences was filed on October 27, 2022 so you should expect the next rating to be made available sometime around October 27, 2023.
分析師在進行了廣泛的研究後獲得了股票評級，其中包括查看公共財務報表，與 Usana Health Sciences 的高管和客戶交談以及收聽盈利會議電話會議。大多數分析師每三個月這樣做一次，因此您應該每年每家公司獲得 4 個評級。Usana 健康科學的最後一個評分於 2022 年 10 月 27 日提交，因此您應該預計下一個評分將在 2023 年 10 月 27 日左右的某個時間提供。
Is the Analyst Rating Usana Health Sciences (USNA) correct?
分析師評級 Usana 健康科學（USNA）是否正確？
While ratings are subjective and will change, the latest Usana Health Sciences (USNA) rating was a maintained with a price target of $57.00 to $49.00. The current price Usana Health Sciences (USNA) is trading at is $61.09, which is out of the analyst's predicted range.
儘管評級是主觀的並且會發生變化，但最新的 Usana 健康科學（USNA）評級維持，目標價格為 $57.00 至 49.00 美元。目前的價格烏薩納健康科學（USNA）的交易價格為 61.09 美元，超出了分析師的預測範圍。
譯文內容由第三人軟體翻譯。